A diagnosis of just “end-stage liver disease” or ESLD is captured with K72. 90 (Hepatic failure, unspecified without coma).
End-stage liver disease (ESLD) is a term synonymous with advanced liver disease, liver failure, and decompensated cirrhosis. It is a progressive illness that develops after inflammatory changes in the liver lead to fibrosis and disruption of liver structure and function.
ICD-10-CM Code for Liver disease, unspecified K76. 9.
End-stage liver disease (ESLD) is synonymous with advanced liver disease, liver failure, and decompensated cirrhosis, given the general irreversibility of these conditions.
BOTTOM LINE. Ascites is the main complication of cirrhosis. It is a landmark of the progression into the decompensated phase of cirrhosis and is associated with a poor prognosis and quality of life; mortality is estimated to be 50% in 2 years.
Symptoms of end-stage liver disease may include: Easy bleeding or bruising. Persistent or recurring yellowing of your skin and eyes (jaundice) Intense itching.
Alcoholic cirrhosis of liver with ascites K70. 31 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM K70. 31 became effective on October 1, 2021.
ICD-10 code K74. 60 for Unspecified cirrhosis of liver is a medical classification as listed by WHO under the range - Diseases of the digestive system .
K74.60 Unspecified cirrhosis of liver.K74.69 Other cirrhosis of liver.
Cirrhosis is classified into four stages that include:Stage I: Steatosis. The first stage of liver disease is characterized by inflammation of the bile duct or liver. ... Stage II: Scarring (fibrosis) of the liver due to inflammation. ... Stage III: Cirrhosis. ... Stage IV: Liver failure or advanced liver disease or hepatic failure.
When liver damage progresses to an advanced stage, fluid collects in the legs, called edema, and in the abdomen, called ascites. Ascites can lead to bacterial peritonitis, a serious infection. When the liver slows or stops producing the proteins needed for blood clotting, a person will bruise or bleed easily.
In the United States, end-stage liver disease (ESLD) is the 12th leading cause of death and the 7th leading cause of death in people between the ages of 25 and 64 years. Complications of ESLD such as ascites, variceal hemorrhage, hepatic encephalopathy, and renal impairment primarily account for these deaths.